USE OF 1-[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]-3-[3-(4-CYANOPHENOXY)PHENYL]UREA IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USED FOR PREVENTING AND/OR TREATING EYE DISEASES

Provided in the present invention is the use of 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(4-cyanophenoxy)phenyl]urea in the preparation of pharmaceutical compositions used for preventing and/or treating eye diseases. 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(4-cyanophenoxy)phenyl]urea inhibits...

Full description

Saved in:
Bibliographic Details
Main Authors CHEN, Kuen-Feng, CHAO, Tzu-i
Format Patent
LanguageChinese
English
French
Published 25.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided in the present invention is the use of 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(4-cyanophenoxy)phenyl]urea in the preparation of pharmaceutical compositions used for preventing and/or treating eye diseases. 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(4-cyanophenoxy)phenyl]urea inhibits angiogenesis in an oxygen-induced retinopathy model, reduces the total node area in the oxygen-induced retinopathy model, alleviates choroidal neovascularization in a laser-induced choroidal neovascularization model, relieves subretinal fibrosis, and reduces the quantities of mRNA and protein expression of collagen 1A1 and fibronectin, thereby achieving the effect of preventing and/or treating eye diseases. La présente invention concerne l'utilisation de 1-[4-chloro-3-(trifluorométhyl)phényl]-3-[3-(4-cyanophénoxy)phényl]urée dans la préparation de compositions pharmaceutiques utilisées pour prévenir et/ou traiter des maladies oculaires. La 1-[4-chloro-3-(trifluorométhyl)phényl]-3-[3-(4-cyanophénoxy)phényl]urée inh
Bibliography:Application Number: WO2023CN72602